首页> 美国卫生研究院文献>Oncology Letters >Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy
【2h】

Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy

机译:积极的切除切缘可能无法反映接受前列腺癌根治术的患者的真实切缘

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to evaluate the hypothesis that a positive resection margin (RM1) of an excised specimen may not reflect the true margin in patients that have undergone radical prostatectomy (RP). Between September 2003 and March 2011, 370 Japanese patients underwent an antegrade RP at the National Kyushu Cancer Center (Fukuoka, Japan), however, 95 of these patients were excluded from the study due to a history of receiving hormonal therapy or insufficient preoperative clinical data. The incidence of biochemical failure (BCF) was evaluated using multivariate analysis, which revealed that the preoperative prostate-specific antigen (PSA) level, pathological tumor stage, RP Gleason score and a PSA nadir <0.008 ng/ml were significant predictors (P=0.0065, 0.0006, 0.0002 and <0.0001, respectively). By contrast, an RM1 was not found to be a significant predictor of BCF, while the parameter with the highest hazard ratio (HR) was a PSA nadir <0.008 ng/ml (HR, 10.055; 95% confidence interval, 5.005–20.200). From the 56 cases that were RM1, 41 cases (73.2%) exhibited a PSA nadir <0.008 ng/ml. There were 42 cases (75.0%) in which only one site was identified to be RM1; among these cases, no significant difference was observed between a PSA level <0.008 ng/ml and a PSA level ≥0.008 ng/ml at the RM1 site (apex, P=0.1460; base, P=0.1384; anterior, P=0.3870; and posterolateral, P=0.5040). There were 14 cases (25.0%) in which multiple sites were RM1; these cases were classified by the number of sites that were RM1 (one vs. multiple) and no significant difference was observed between a PSA level <0.008 ng/ml and a PSA level ≥0.008 ng/ml (P=0.6090). Based on these results, an RM1 of an excised specimen may not reflect the true margin in patients that are treated with RP, specifically in cases where the PSA level is identified to decrease to below the postoperative measurement threshold value (PSA nadir <0.008 ng/ml).
机译:本研究的目的是评估以下假设:切除的标本的阳性切除切缘(RM1)可能无法反映接受前列腺癌根治术(RP)的患者的真实切缘。在2003年9月至2011年3月之间,有370名日本患者在国立九州癌症中心(日本福冈)进行了顺行RP,但是,由于接受激素治疗史或术前临床资料不足,这些患者中有95名被排除在研究之外。 。使用多变量分析评估了生化衰竭(BCF)的发生率,这表明术前前列腺特异性抗原(PSA)水平,病理肿瘤分期,RP Gleason评分和PSA最低点<0.008 ng / ml是重要的预测指标(P =分别为0.0065、0.0006、0.0002和<0.0001)。相比之下,没有发现RM1是BCF的重要预测指标,而具有最高危险比(HR)的参数是PSA最低点<0.008 ng / ml(HR,10.055; 95%置信区间,5.005-20.200) 。在RM1的56例中,有41例(73.2%)的PSA最低值<0.008 ng / ml。在42例(75.0%)中,只有一个站点被确定为RM1;在这些病例中,在RM1位点的PSA水平<0.008 ng / ml和PSA水平≥0.008ng / ml之间没有观察到显着差异(顶点,P = 0.1460;基础,P = 0.1384;前部,P = 0.3870;后外侧,P = 0.5040)。有14例(25.0%)的多个网站为RM1;这些病例按RM1的部位数目进行分类(一个vs.多个),在PSA水平<0.008 ng / ml和PSA水平≥0.008ng / ml之间没有发现显着差异(P = 0.6090)。根据这些结果,切除的标本的RM1可能无法反映接受RP治疗的患者的真实余量,特别是在PSA水平被确定降至术后测量阈值以下的情况下(PSA nadir <0.008 ng /毫升)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号